CoChat

Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer

Open access
Rönnau, C. G. H., Fussek, S., Smit, F. P., Aalders, T. W., van Hooij, O., Pinto, P. M. C., Burchardt, M., Schalken, J. A., Verhaegh, G. W. · 2021 · World Journal of Urology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

PURPOSE: Prostate cancer (PCa) is a leading cause of cancer-related death. Upon androgen-deprivation therapy, the disease may progress further to castration-resistant PCa (CRPC) with a poor prognosis. MicroRNAs (miRNAs) are small non-coding RNAs, which play crucial roles in gene regulation. The aim of our study is to find CRPC-associated miRNAs and to evaluate their functional role. METHODS: In this study, 23 benign prostatic hyperplasia (BPH), 76 primary PCa, and 35 CRPC specimens were included. Total RNA extracted from tissue sections was used for miRNA profiling on the Affymetrix GSC 3000 platform. Subsequently, stem-loop RT-qPCR analysis was performed to validate the expression levels of selected miRNAs. PCa cell lines were transfected with miRNA mimics or inhibitors to evaluate the effects on cell proliferation, cell migration and cell invasion. RESULTS: In our profiling study, several miRNAs were found to be deregulated in CRPC compared to primary PCa tissue, of which miR-205 (- 4.5-fold; p = 0.0009), miR-92b (- 3.1 fold; p < 0.0001) were downregulated and miR-3195 (5.6-fold; p < 0.0001), miR-3687 (8.7-fold; p = 0.0006) and miR-4417 (5.0-fold; p = 0.0005) were most upregulated. While KLK3, miR-21 and miR-141 expression levels in androgen-treated VCaP and LNCaP cells were increased, the expression levels of miR-3687 and miR-4417 were reduced. None of the miRNAs were androgen-regulated in the AR-negative PC3 cell line. Overexpression of miR-3687 reduced cell migration and cell invasion, whilst miR-3195 enhanced cell migration. CONCLUSION: We have identified several novel deregulated miRNAs in CRPC tissue, including two microRNAs that are potentially involved in tumor invasion. Our data support the hypothesized involvement of miRNAs in PCa tumorigenesis and progression to CRPC. The applicability of these miRNAs as novel biomarkers for CRPC remains to be further investigated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00345-021-03723-4

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Expression of miR-205, miR-3195, miR-3687, and miR-4417 in human prostate tissue and their association with CRPC. MiRNA expression analysis was performed by stem-loop RT-qPCR analysis. The results were normalized to the weighted average of miR-26a, miR-107 and RNU6 levels. The median expression and the standard deviation are shown; outliers are indicated by open circles and asterisks. MiR-205 a is significantly downregulated, whilst miR-3195 b, miR-3687 c and miR-4417 d are significantly upregulated in CRPC tissue compared to primary PCa tissue. BPH, benign prostate hyperplasia; LG, low grade prostate cancer; HG, high grade prostate cancer; CRPC, castration-resistant prostate cancer. e, f Receiver operating characteristic curve (ROC) analysis was performed using miRNA expression data from the validation set (n = 83), comparing the ability of miR-3195, miR-3687, miR-4417 alone and combinations of miR-3195 and miR-3687, and of miR-205, miR-3195 and miR-4417 to identify men with CRPC. Areas under the curve (AUC) are shown (*p < 0.01)
Fig. 1 Expression of miR-205, miR-3195, miR-3687, and miR-4417 in human prostate tissue and their association with CRPC. MiRNA expression analysis was performed by stem-loop RT-qPCR analysis. The results were normalized to the weighted average of miR-26a, miR-107 and RNU6 levels. The median expression and the standard deviation are shown; outliers are indicated by open circles and asterisks. MiR-205 a is significantly downregulated, whilst miR-3195 b, miR-3687 c and miR-4417 d are significantly upregulated in CRPC tissue compared to primary PCa tissue. BPH, benign prostate hyperplasia; LG, low grade prostate cancer; HG, high grade prostate cancer; CRPC, castration-resistant prostate cancer. e, f Receiver operating characteristic curve (ROC) analysis was performed using miRNA expression data from the validation set (n = 83), comparing the ability of miR-3195, miR-3687, miR-4417 alone and combinations of miR-3195 and miR-3687, and of miR-205, miR-3195 and miR-4417 to identify men with CRPC. Areas under the curve (AUC) are shown (*p < 0.01)CC BY · PubMed Central
Fig. 2 Androgen responsiveness of CRPC-associated miRNAs. Analysis of KLK3 a, miR-21 b, miR-141 c, miR-3195 d, miR-3687 e and miR-4417 f expression in VCaP cells. VCaP cells were cultured for 3 days in androgen-free (CSS) medium, and then incubated in the presence of 0.1, 1 or 10 nM of synthetic androgen R1881. Total RNA was extracted 24 and 48 h after androgen stimulation. KLK3 and miRNA levels were determined by reverse transcriptase real-time PCR analysis. HPRT1 and RNU6 levels were used for normalization purposes. All experiments were repeated at least three times; p-values were calculated with the unpaired t-test (*p < 0.05; **p < 0.01; ***p < 0.001)
Fig. 2 Androgen responsiveness of CRPC-associated miRNAs. Analysis of KLK3 a, miR-21 b, miR-141 c, miR-3195 d, miR-3687 e and miR-4417 f expression in VCaP cells. VCaP cells were cultured for 3 days in androgen-free (CSS) medium, and then incubated in the presence of 0.1, 1 or 10 nM of synthetic androgen R1881. Total RNA was extracted 24 and 48 h after androgen stimulation. KLK3 and miRNA levels were determined by reverse transcriptase real-time PCR analysis. HPRT1 and RNU6 levels were used for normalization purposes. All experiments were repeated at least three times; p-values were calculated with the unpaired t-test (*p < 0.05; **p < 0.01; ***p < 0.001)CC BY · PubMed Central
Fig. 3 Effect of CRPC-associated miRNAs on cell survival. PC3 a–c, f and VCaP d–e cells were transfected with miRNA mimics (10–50 nM) or with anti-miR miRNA inhibitors (50 nM). Total RNA was extracted and the relative expression of miR-3687 was determined by stem-loop RT-qPCR analysis, using RNU6 for normalization a, d. Cell viability of miRNA mimic or anti-miR transfected cells was determined at different time points post-transfection b, c, e. Transfected cells were seeded 2 days post-transfection in 96-well plates. Cell viability was determined from day 1 until day 5 (PC3) or day 11 (VCaP), using CellTiter-Glo Assays. Apoptosis of miRNA mimic and anti-miR transfected PC3 cells was determined 2 days post transfection, using a Caspase-3/7 Assay f. NT non-transfected cells. Error bars indicate the standard deviation of at least 2 independent experiments
Fig. 3 Effect of CRPC-associated miRNAs on cell survival. PC3 a–c, f and VCaP d–e cells were transfected with miRNA mimics (10–50 nM) or with anti-miR miRNA inhibitors (50 nM). Total RNA was extracted and the relative expression of miR-3687 was determined by stem-loop RT-qPCR analysis, using RNU6 for normalization a, d. Cell viability of miRNA mimic or anti-miR transfected cells was determined at different time points post-transfection b, c, e. Transfected cells were seeded 2 days post-transfection in 96-well plates. Cell viability was determined from day 1 until day 5 (PC3) or day 11 (VCaP), using CellTiter-Glo Assays. Apoptosis of miRNA mimic and anti-miR transfected PC3 cells was determined 2 days post transfection, using a Caspase-3/7 Assay f. NT non-transfected cells. Error bars indicate the standard deviation of at least 2 independent experimentsCC BY · PubMed Central
Fig. 4 Effect of CRPC miRNAs on cell migration and cell invasion. Cell migration a was assessed by wound-healing “scratch” assays. Error bars indicate the standard deviation of at least four independent experiments performed in triplicate. Cell invasion b was determined using Matrigel-coated 8-µm cell invasion chambers. PC3 cells were transfected with miRNA mimics (10–50 nM) or with anti-miR miRNA inhibitors. Inhibition of cell invasion by a specific miRNA was calculated by dividing the percentage of invaded cells versus that of NC2 transfected cells. NT non-transfected cells. Error bars indicate the standard deviation of two independent experiments performed in duplicate; p values were calculated with the unpaired t-test (*p < 0.05; ***p < 0.001)
Fig. 4 Effect of CRPC miRNAs on cell migration and cell invasion. Cell migration a was assessed by wound-healing “scratch” assays. Error bars indicate the standard deviation of at least four independent experiments performed in triplicate. Cell invasion b was determined using Matrigel-coated 8-µm cell invasion chambers. PC3 cells were transfected with miRNA mimics (10–50 nM) or with anti-miR miRNA inhibitors. Inhibition of cell invasion by a specific miRNA was calculated by dividing the percentage of invaded cells versus that of NC2 transfected cells. NT non-transfected cells. Error bars indicate the standard deviation of two independent experiments performed in duplicate; p values were calculated with the unpaired t-test (*p < 0.05; ***p < 0.001)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 29

Metadata

Authors
Rönnau, C. G. H., Fussek, S., Smit, F. P., Aalders, T. W., van Hooij, O., Pinto, P. M. C., Burchardt, M., Schalken, J. A., & Verhaegh, G. W.
Affiliations
  • Universitätsmedizin Greifswald (DE)
  • MDxHealth (Netherlands) (NL)
  • Radboud University Medical Center (NL)
Corresponding author
Verhaegh, G. W.
Venue
World Journal of Urology
Published
2021-05-14
Volume
39
Issue
10
Pages
3789-3797
ISSN
  • 0724-4983 (ISSN-L)
  • 1433-8726
OpenAlex
W3163788247
Cited by
28
References
31
Citations by year
2026: 6 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 6
FWCI
1.79
Type
journal article
Language
en
Open access
Licence
Locations
  • World Journal of Urology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
European Association of Urology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords
castration-resistant prostate cancer, miRNA expression profiling, miR-205, miR-92b, androgen deprivation therapy, tumor invasion, cell migration, cell proliferation, KLK3, miR-21, miR-141
MeSH terms
PC-3 Cells, Aged, Cell Movement, Humans, Male, Middle Aged, Neoplasm Invasiveness, Prostatic Hyperplasia, Prostatic Neoplasms, Up-Regulation, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Prostatic Neoplasms, Castration-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer. https://app.cochat.ai/papers/10.1007/s00345-021-03723-4
The paper
Rönnau, C. G. H., Fussek, S., Smit, F. P., Aalders, T. W., van Hooij, O., Pinto, P. M. C., Burchardt, M., Schalken, J. A., & Verhaegh, G. W. (2021). Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer. World Journal of Urology. https://doi.org/10.1007/s00345-021-03723-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.